CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.7451
-0.0549 (-6.86%)
At close: Jul 21, 2025, 4:00 PM
8.94
-0.00 (-0.01%)
Pre-market: Jul 22, 2025, 9:02 AM EDT
CNS Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for CNS Pharmaceuticals.
Price Target: n/a
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for CNS Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $300 | Hold → Strong Buy | Upgrades | $300 | +40,163.05% | Sep 10, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9,000,000 | Strong Buy | Initiates | $9,000,000 | +1,207,891,458.18% | Feb 2, 2021 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $9,900,000 | Strong Buy | Initiates | $9,900,000 | +1,328,680,614.00% | Aug 24, 2020 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-23.02
from -38.87
EPS Next Year
-1.41
from -23.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | 38.8M |
| Avg | n/a | n/a | 37.7M |
| Low | n/a | n/a | 36.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.15 | -1.21 | -1.00 |
| Avg | -23.02 | -1.41 | -1.41 |
| Low | -41.29 | -1.58 | -1.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.